HIGHLIGHTS
- who: Wenxin Zhu and colleagues from the National Institute of Virology (ICMR), India Johns Hopkins University have published the Article: Third dose of anti-SARS-CoV-2 inactivated vaccine for patients with RA: Focusing on immunogenicity and effects of RA drugs, in the Journal: (JOURNAL)
- what: NAb titer levels are positively correlated with vaccine protection, and ongoing disease surveillance studies can be conducted to assess vaccine protection's durability better. frontiersin.org 10.3389/fmed.2022.978272 than HC. The study showed that serum antibody responses to the third dose of vaccine in RA patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.